Ovarian cancer is the sixth most common malignancy among women in developed countries and the fifth leading cause of cancer-related death, representing a complex disease associated with poor survival rates.24 The combination chemotherapy of Paclitaxel (PTX) and Carboplatin (CARB) is considered the first-line treatment regimen for ovarian cancer.25 Both agents play distinct roles in inhibiting the growth of ovarian cancer through different mechanisms,26 and they are known to exert a synergistic anti-tumor effect by activating separate apoptotic signaling pathways, thereby potentially reducing drug resistance.25 The gonadotoxic effects of platinum-based chemotherapeutic agents have been demonstrated in numerous studies, both histopathologically and in terms of follicular development.27-29 In the present study, CARB administration led to significant histopathological damage in ovarian tissue, including follicular degeneration, prominent stromal edema, congestion, hemorrhage, inflammation, and fibrosis, particularly in the medullary region
Scientific Activity Glutathione cycles between reduced (GSH) and oxidized (GSSG) forms, transferring reducing equivalents in redox reactions and serving as a cofactor for glutathione-dependent enzymes
Take it before you do anything else
India's market is emerging as consumers explore herbal beverages beyond traditional tea
When it outpaces neutralization by enzymes like superoxide dismutase and small-molecule antioxidants such as glutathione, harm builds up
